American Journal of Kidney Diseases
Volume 55, Issue 1 , Pages 77-87, January 2010

Short-term Effects of Online Hemodiafiltration on Phosphate Control: A Result From the Randomized Controlled Convective Transport Study (CONTRAST)

  • E. Lars Penne, MD, PhD

      Affiliations

    • Department of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands
    • Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands
  • ,
  • Neelke C. van der Weerd, MD

      Affiliations

    • Department of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands
    • Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands
  • ,
  • Marinus A. van den Dorpel, MD, PhD

      Affiliations

    • Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands
  • ,
  • Muriel P.C. Grooteman, MD, PhD

      Affiliations

    • Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands
    • Institute for Cardiovascular Research, VU Medical Center, Amsterdam, The Netherlands
  • ,
  • Renée Lévesque, MD

      Affiliations

    • Department of Nephrology, Centre Hospitalier de l'Université de Montréal, St-Luc Hospital, Québec, Canada
  • ,
  • Menso J. Nubé, MD, PhD

      Affiliations

    • Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands
    • Institute for Cardiovascular Research, VU Medical Center, Amsterdam, The Netherlands
  • ,
  • Michiel L. Bots, MD, PhD

      Affiliations

    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
  • ,
  • Peter J. Blankestijn, MD, PhD

      Affiliations

    • Department of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands
  • ,
  • Piet M. ter Wee, MD, PhD

      Affiliations

    • Department of Nephrology, VU Medical Center, Amsterdam, The Netherlands
    • Institute for Cardiovascular Research, VU Medical Center, Amsterdam, The Netherlands
    • Corresponding Author InformationAddress correspondence to Piet M. ter Wee, MD, PhD, Department of Nephrology, VU Medical Center, De Boelelaan 1117, 1081 HV Amsterdam, The Netherlands
  • ,
  • CONTRAST Investigators

Received 6 April 2009; accepted 24 September 2009. published online 07 December 2009.

Background

Hyperphosphatemia is an independent risk factor for all-cause and cardiovascular mortality in hemodialysis (HD) patients. Phosphate control often is unsuccessful using conventional dialysis therapies.

Study Design

Short-term analysis of a secondary outcome of an ongoing randomized controlled trial.

Setting & Participants

493 (84%) consecutive patients from 589 patients included in the Convective Transport Study (CONTRAST) by January 2009 from 26 centers in 3 countries.

Intervention

Online hemodiafiltration (HDF) versus continuation of low-flux HD.

Outcomes

Differences in change from baseline to 6 months in phosphate levels and proportion of patients reaching phosphate treatment targets (phosphate ≤ 5.5 mg/dL).

Measurements

Phosphate, use of phosphate-binding agents, and proportion of patients achieving treatment targets at baseline, 3 months, and 6 months.

Results

Phosphate levels decreased from 5.18 ± 0.10 (SE) mg/dL at baseline to 4.87 ± 0.10 mg/dL at 6 months in HDF patients (P < 0.001) and were stable in HD patients (5.10 ± 0.10 mg/dL at baseline and 5.03 ± 0.10 mg/dL after 6 months; P = 0.5). The difference in change in phosphate levels between HD and HDF patients (B = −0.24; 95% CI, −0.52 to 0.03; P = 0.08) increased after adjustment for phosphate-binder use (B = −0.36; 95% CI, −0.65 to −0.06; P = 0.02). The proportion of patients reaching phosphate treatment targets increased from 64% to 74% in HDF patients and was stable in HD patients (66% and 66%); the difference between groups reached statistical significance (P = 0.04). Nutritional parameters and residual renal function were similar in both treatment groups.

Limitations

Only predialysis serum phosphate levels were measured; phosphate clearance could therefore not be calculated.

Conclusion

HDF may help improve phosphate control. Whether this contributes to improved clinical outcome remains to be established.

Index Words: Convective clearance, hemodiafiltration, hemodialysis, nutrition, phosphate, phosphate-binding agents, residual renal function, treatment targets

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 A list of the members of the CONTRAST Investigators appears at the end of this article.

 Originally published online as doi:10.1053/j.ajkd.2009.09.023 on December 7, 2009.

 Trial registration: www.ClinicalTrials.gov; study number: NCT00205556.

PII: S0272-6386(09)01309-2

doi:10.1053/j.ajkd.2009.09.023

American Journal of Kidney Diseases
Volume 55, Issue 1 , Pages 77-87, January 2010